Please login to the form below

Not currently logged in
Email:
Password:

Arix Biosciences

This page shows the latest Arix Biosciences news and features for those working in and with pharma, biotech and healthcare.

Blood disorder specialists Imara raises $63m

Blood disorder specialists Imara raises $63m

Arix Biosciences claims a 10% stake in the biotech. US biotech Imara has just closed a $63m series B financing round to further develop therapeutics for the treatment of blood disorders. ... In return, Arix owns 10% of the company and Investment Director

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Former Roche CEO and chairman joins Arix Bioscience Former Roche CEO and chairman joins Arix Bioscience

    Jonathan Peacock, chairman of Arix Bioscience, said: “We are delighted to welcome to the board a director of Franz's stature. ... His experience and judgement will be a tremendous asset to Arix Bioscience as we continue to support emerging and

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics